Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1705-1716 of 1735 results
Page 143 of 145
Key Publications August 20, 2008

Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA).

Arch Intern Med 2008 ;168:1333-9

Folsom AR, Kronmal RA, Detrano RC et al.
Cardiovascular Disease Clinical Cardiology Prevention
Key Publications July 26, 2008

Update on obesity.

J Clin Endocrinol Metab 2008 ;93:2027-34

Bessesen DH
Prevention
Key Publications July 11, 2008

Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial.

JAMA 2008; 299:1139-48

Svetkey LP, Stevens VJ, Brantley PJ et al.
Prevention
Key Publications July 10, 2008

The epidemiology of obesity: the size of the problem.

J Intern Med. 2008;263:336-52

James WP.
Prevention
Key Publications July 9, 2008

Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.

Metabolism 2008;57:796-801

Tribble DL, Farnier M, Macdonell G et al.
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications June 24, 2008

Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.

Arterioscler Thromb Vasc Biol 2008;28:1172-8

Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications June 5, 2008

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.

Lancet 2008;371:1999-2012

Wood DA, Kotseva K, Connolly S et al.
Prevention
Key Publications May 22, 2008

Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.

J Am Coll Cardiol 2008;51:1448-54

Shepherd J, Kastelein JJ, Bittner V et al.
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications May 16, 2008

Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.

Am Heart J 2008;155:499.e9-16

Rosenson RS
Lipids/Lipoproteins Metabolic Syndrome Prevention
Key Publications May 12, 2008

Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.

Am J Cardiol 2008;10:36B-43B

Taylor AJ
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications May 5, 2008

Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.

Am J Cardiol 2008;101:315-8

Ai M, Otokozawa S, Asztalos BF et al.
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications May 2, 2008

Lipoprotein(a) Levels and risk of future coronary heart disease: large-scale prospective data.

Arch Intern Med 2008;168:598-608

Bennet A, Di Angelantonio E, Erqou S et al.
Cardiovascular Disease Lipids/Lipoproteins Prevention
of 145